Several strains of Gram-pos bacilli)-shaped bacteria were cultured turbot, Scophthalmi North of Spai treptoc is. The a-hae olytic reptoc lS-lik( : identified b] physiological, biochemical and 16S rRNA sequence analysis as Streptococcus parauberis. T the First report of S. parauberis associated wit!
A PCR-based method was developed for the specific detection ofYersinia ruckeri in tissues of inoculated trout and naturally infected trout. No amplification products were obtained with other yersiniae, bacterial fish pathogens, or phylogenetically related bacteria (n = 34). The sensitivity of PCR detection was 60 to 65 bacterial cells per PCR tube, which was decreased to 10 to 20 cells by hybridization with a nonradioactive probe. The PCR assay proved to be as reliable as and faster than the conventional culture method for the detection of Y. ruckeri in infected trout tissues.
1. A study was undertaken to evaluate the effects of the inclusion of linseed or demucilaged linseed in the diet on the performance, fat and fatty acid digestibilities, metabolisability of gross energy and intestinal microflora. 2. The dietary inclusions were 80 and 160 g/kg for linseed and 160 g/kg for demucilaged linseed. Diets were given to chickens from 1 to 23 d of age. 3. Incorporation of linseed in the diet, particularly at 160 g/kg, depressed weight gain and food utilisation. Digestibility of fat and single fatty acids and dietary metabolisable energy were reduced. 4. Inclusion of linseed in the diet markedly increased the viscosity of ileal digesta. Microbial activity in the ileum and caeca was not greatly affected, but there was a significant increase in the number of lactobacilli. 5. The antinutritional effects caused by feeding linseed were partially overcome by substituting demucilaged linseed for linseed in the diet. 6. Results from the current study suggest that the viscous properties of mucilage are a major factor in the observed antinutritional effects of linseed through increasing intestinal viscosity. Such effects might also be mediated by the gut microflora.
The present work describes the molecular characterization of five circular plasmids found in the human clinical strain
Lactococcus garvieae
21881. The plasmids were designated pGL1-pGL5, with molecular sizes of 4,536 bp, 4,572 bp, 12,948 bp, 14,006 bp and 68,798 bp, respectively. Based on detailed sequence analysis, some of these plasmids appear to be mosaics composed of DNA obtained by modular exchange between different species of lactic acid bacteria. Based on sequence data and the derived presence of certain genes and proteins, the plasmid pGL2 appears to replicate via a rolling-circle mechanism, while the other four plasmids appear to belong to the group of lactococcal theta-type replicons. The plasmids pGL1, pGL2 and pGL5 encode putative proteins related with bacteriocin synthesis and bacteriocin secretion and immunity. The plasmid pGL5 harbors genes (
txn, orf5
and
orf25
) encoding proteins that could be considered putative virulence factors. The gene
txn
encodes a protein with an enzymatic domain corresponding to the family actin-ADP-ribosyltransferases toxins, which are known to play a key role in pathogenesis of a variety of bacterial pathogens. The genes
orf5
and
orf25
encode two putative surface proteins containing the cell wall-sorting motif LPXTG, with mucin-binding and collagen-binding protein domains, respectively. These proteins could be involved in the adherence of
L. garvieae
to mucus from the intestine, facilitating further interaction with intestinal epithelial cells and to collagenous tissues such as the collagen-rich heart valves. To our knowledge, this is the first report on the characterization of plasmids in a human clinical strain of this pathogen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.